A fourth patient with an INI1-deficient clival chordoma received nivolumab after receiving 4 cycles of vincristine, doxorubicin and cyclophosphamide with alternating ifosfamide and etoposide (15). This evidence concerns the gene SMARCB1 and chordoma.